Movatterモバイル変換


[0]ホーム

URL:


AU2003237076A1 - Therapeutical use of anti-cd70 antibody for treating or preventing aids - Google Patents

Therapeutical use of anti-cd70 antibody for treating or preventing aids

Info

Publication number
AU2003237076A1
AU2003237076A1AU2003237076AAU2003237076AAU2003237076A1AU 2003237076 A1AU2003237076 A1AU 2003237076A1AU 2003237076 AAU2003237076 AAU 2003237076AAU 2003237076 AAU2003237076 AAU 2003237076AAU 2003237076 A1AU2003237076 A1AU 2003237076A1
Authority
AU
Australia
Prior art keywords
antibody
treating
therapeutical use
preventing aids
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003237076A
Inventor
Rene Antonius Wilhelmus Van Lier
Marinus Hendricus Jozef Van Oers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Sanquin Bloedvoorziening
Original Assignee
Stichting Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Sanquin BloedvoorzieningfiledCriticalStichting Sanquin Bloedvoorziening
Publication of AU2003237076A1publicationCriticalpatent/AU2003237076A1/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU2003237076A2003-05-232003-05-23Therapeutical use of anti-cd70 antibody for treating or preventing aidsAbandonedAU2003237076A1 (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
PCT/NL2003/000385WO2004104045A1 (en)2003-05-232003-05-23Therapeutical use of anti-cd70 antibody for treating or preventing aids

Publications (1)

Publication NumberPublication Date
AU2003237076A1true AU2003237076A1 (en)2004-12-13

Family

ID=33476091

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU2003237076AAbandonedAU2003237076A1 (en)2003-05-232003-05-23Therapeutical use of anti-cd70 antibody for treating or preventing aids

Country Status (2)

CountryLink
AU (1)AU2003237076A1 (en)
WO (1)WO2004104045A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20080025989A1 (en)2003-02-202008-01-31Seattle Genetics, Inc.Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
DK1594542T3 (en)2003-02-202010-10-11Seattle Genetics Inc Anti-CD70 antibody-drug conjugates and their use in the treatment of cancer
JP5222559B2 (en)2004-10-152013-06-26シアトル ジェネティックス, インコーポレイテッド Anti-CD70 antibodies and uses thereof for the treatment and prevention of cancer and immune disorders
US8337838B2 (en)2004-10-152012-12-25Seattle Genetics, Inc.Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
NZ566395A (en)*2005-09-262012-03-30Medarex IncHuman monoclonal antibodies to CD70
EP3041868A2 (en)2013-09-052016-07-13Aduro Biotech Holdings, Europe B.V.Cd70-binding peptides and method, process and use relating thereto
CN116490210A (en)*2020-11-232023-07-25山东先声生物制药有限公司CD70 antibody and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6312700B1 (en)*1998-02-242001-11-06Andrew D. WeinbergMethod for enhancing an antigen specific immune response with OX-40L

Also Published As

Publication numberPublication date
WO2004104045A1 (en)2004-12-02

Similar Documents

PublicationPublication DateTitle
IL173386A0 (en)Use of adcc-optimized antibodies for treating weak patients
AU2003224788A1 (en)Method for treatment of tissue
AU2004255187A1 (en)Device for treatment of human or animal barrier membranes
AU2003298043A1 (en)Surface treatment of medical device
AU2003249244A1 (en)Methods for the treatment of neoplasms
AU2002310187A1 (en)Inhibitors of protein kinase for the treatment of disease
AU2002332430A1 (en)Methods of treating neuropilin-mediated diseases
AU2002257936A1 (en)Methods of well treatment
DE60322451D1 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
GB0329874D0 (en)Compounds useful for the treatment of diseases
IL175412A0 (en)Use of specific histones for the treatment of parasitic diseases
AU2003260778A1 (en)Treatment of pipes
AU2003237076A1 (en)Therapeutical use of anti-cd70 antibody for treating or preventing aids
AU2003223538A1 (en)Methods for the treatment of cancer
AU2003259833A1 (en)Methods of treating neurodegenerative diseases
AU2003249930A1 (en)Proteaseome inhibitors for the treatment of herpesviridae infected individuals
AU2003277728A1 (en)Apparatus for the biological treatment of wastewater
EP1691776A4 (en)Treatment of aids
AU2003221005A1 (en)Method of wastewater treatment
AU2004281077A1 (en)Methods and agents for the treatment of cancer
AU2002249891A1 (en)Compounds and methods for the diagnosis and treatment of babesia infection
AU2001281465A1 (en)Treatment of rosacea
AU2002343085A1 (en)Tnf-alpha inhibitors for the treatment of hepatic diseases
AU2003208809A1 (en)Treatment of neuroblastoma
AU2003304316A1 (en)Compounds and methods for the treatment and prevention of bacterial infection

Legal Events

DateCodeTitleDescription
MK6Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

[8]ページ先頭

©2009-2025 Movatter.jp